+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Whole Slide Imaging - Global Strategic Business Report

  • PDF Icon

    Report

  • 197 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140020
The global market for Whole Slide Imaging was estimated at US$890.7 Million in 2023 and is projected to reach US$2.9 Billion by 2030, growing at a CAGR of 18.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Whole Slide Imaging Market - Key Trends & Drivers Summarized

Why Is Whole Slide Imaging Transforming Pathology and Diagnostic Practices?

Whole Slide Imaging (WSI) is revolutionizing the field of pathology and diagnostic practices by enabling the digitization of entire histological slides, allowing for high-resolution examination, storage, and sharing of pathology slides. This technology facilitates remote consultations, digital archiving, and AI-driven analysis, enhancing the accuracy and efficiency of diagnostics in oncology, hematology, and infectious diseases. The increasing adoption of digital pathology, driven by the need for improved diagnostic workflows, telepathology, and the integration of artificial intelligence, is propelling the demand for WSI systems. With the rise of personalized medicine and the need for precise and reproducible diagnostic data, WSI is becoming a crucial tool in modern healthcare.

How Are Technological Advancements Enhancing Whole Slide Imaging Systems?

Technological advancements in imaging hardware, data management, and artificial intelligence are significantly enhancing the capabilities and applications of whole slide imaging systems. The development of high-speed scanners with higher resolution and depth of focus is enabling more accurate and detailed visualization of tissue morphology and pathology. Innovations in data compression and cloud storage solutions are improving the handling, storage, and retrieval of large image datasets, facilitating seamless digital workflows in pathology labs. Additionally, the integration of AI and machine learning algorithms is enabling automated image analysis, pattern recognition, and predictive diagnostics, reducing the workload on pathologists and increasing diagnostic accuracy. These advancements are driving the adoption of WSI in clinical diagnostics, research, and education.

What Are the Challenges and Opportunities in the Whole Slide Imaging Market?

The whole slide imaging market faces several challenges, including high initial costs of WSI systems, data management complexities, and the need for standardization and interoperability across digital pathology platforms. Additionally, regulatory hurdles and the need for validation of digital pathology systems for clinical use can slow down adoption. However, these challenges also present opportunities for growth and innovation. The development of cost-effective and scalable WSI solutions that offer high-quality imaging, easy integration with existing lab infrastructure, and robust data management capabilities can help drive adoption in both clinical and research settings. The increasing demand for telepathology and remote diagnostics, driven by the need for second opinions and specialized expertise, is creating new growth opportunities for WSI systems that support seamless digital consultation and collaboration. Moreover, the rising focus on AI-driven diagnostics and precision medicine is driving the need for advanced WSI solutions that provide reliable and reproducible data for clinical decision-making.

What Is Driving the Growth of the Whole Slide Imaging Market?

The growth in the Whole Slide Imaging market is driven by several factors, including the increasing adoption of digital pathology, rising demand for telepathology and remote diagnostics, and technological advancements in imaging hardware, data management, and AI-driven analysis. The need for improved diagnostic accuracy, efficiency, and collaboration in pathology is significantly boosting market demand for WSI systems in clinical and research settings. Technological innovations in high-resolution imaging, cloud storage, and AI-based analytics are enhancing the capabilities and scalability of WSI systems, making them more attractive to hospitals, research institutes, and diagnostic labs. The expansion of personalized medicine and the growing emphasis on digital healthcare transformation are also driving market growth as stakeholders seek advanced digital pathology tools to enhance diagnostic workflows and patient outcomes.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Whole Slide Imaging Hardware segment, which is expected to reach US$1.5 Billion by 2030 with a CAGR of a 18.9%. The Whole Slide Imaging Software segment is also set to grow at 17.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $241.5 Million in 2023, and China, forecasted to grow at an impressive 16.9% CAGR to reach $424.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Whole Slide Imaging Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Whole Slide Imaging Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Whole Slide Imaging Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as 3DHISTECH Ltd., Definiens AG, Hamamatsu Photonics KK, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 47 Featured):

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Whole Slide Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Digital Pathology Solutions Drives Whole Slide Imaging Market
  • Technological Advancements in Imaging and Analysis Propel Market Growth
  • Increased Adoption in Clinical Diagnostics Enhances Whole Slide Imaging Utilization
  • Growth in Cancer Research Necessitates Efficient Whole Slide Imaging Solutions
  • Integration of AI and Machine Learning in Image Analysis Expands Capabilities
  • Global Expansion of Telepathology Services Amplifies Whole Slide Imaging Demand
  • Regulatory and Compliance Requirements Influence Whole Slide Imaging Adoption
  • Developments in High-Throughput Scanning Technologies Boost Market Efficiency
  • Rising Healthcare Expenditure Worldwide Sustains Investment in Digital Imaging
  • Technological Convergence in Healthcare IT Systems Promotes Interoperability
  • Data Management and Storage Challenges Drive Solutions in Digital Pathology
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Whole Slide Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Telepathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Telepathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Cytopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Cytopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Hematopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for Hematopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 18: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 19: USA 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 20: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: USA 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
CANADA
  • Table 22: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 23: Canada 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 24: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 25: Canada 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
JAPAN
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: Japan 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 28: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 29: Japan 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
CHINA
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 30: China Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 31: China 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 32: China Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: China 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
EUROPE
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 34: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 35: Europe 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 36: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 37: Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 38: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
FRANCE
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 40: France Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 41: France 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 42: France Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 43: France 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
GERMANY
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 44: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Germany 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 46: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: Germany 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
ITALY
  • Table 48: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: Italy 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 50: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Italy 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
UNITED KINGDOM
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 52: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 53: UK 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 54: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 55: UK 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
REST OF EUROPE
  • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Rest of Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 59: Rest of Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
ASIA-PACIFIC
  • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 61: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
REST OF WORLD
  • Table 64: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 65: Rest of World 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
  • Table 66: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 67: Rest of World 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

Table Information